Lv1
40 积分 2024-12-05 加入
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
5个月前
已完结
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
5个月前
已完结
BMP Signaling in Development, Stem Cells, and Diseases of the Gastrointestinal Tract
8个月前
已完结
皖公网安备34019202002308
